Use of the drug aleglitazar has shown the ability to lower glucose levels and have favorable effects on cholesterol. It did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a iJAMA/i study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. Cardiovascular disease remains the dominant ...Sunday 30 March 2014
Medication Does Not Reduce Risk of Recurrent CV Events Among Diabetes Patients
Use of the drug aleglitazar has shown the ability to lower glucose levels and have favorable effects on cholesterol. It did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a iJAMA/i study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. Cardiovascular disease remains the dominant ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment